These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2471825

  • 1. Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
    Balster RL.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):749-56. PubMed ID: 2471825
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE.
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
    Holtzman SG.
    Pharmacol Biochem Behav; 1993 Feb; 44(2):349-55. PubMed ID: 8446667
    [Abstract] [Full Text] [Related]

  • 4. Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.
    Steinfels GF, Tam SW, Cook L.
    Psychopharmacology (Berl); 1987 Feb; 91(1):5-9. PubMed ID: 3029793
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
    Picker MJ.
    Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist.
    Slifer BL, Dykstra LA.
    Life Sci; 1987 Jan 26; 40(4):343-9. PubMed ID: 3027481
    [Abstract] [Full Text] [Related]

  • 7. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD, Mueller ZL, Gannon RL, Silverman PB, Johnson KM.
    J Pharmacol Exp Ther; 1984 Nov 26; 231(2):261-9. PubMed ID: 6092611
    [Abstract] [Full Text] [Related]

  • 8. Effects of drugs that bind to PCP and sigma receptors on punished responding.
    McMillan DE, Hardwick WC, deCosta BR, Rice KC.
    J Pharmacol Exp Ther; 1991 Sep 26; 258(3):1015-8. PubMed ID: 1653832
    [Abstract] [Full Text] [Related]

  • 9. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
    Itzhak Y, Hiller JM, Simon EJ.
    Mol Pharmacol; 1985 Jan 26; 27(1):46-52. PubMed ID: 3965930
    [Abstract] [Full Text] [Related]

  • 10. Effects of phencyclidine-like drugs on punished behavior in rats.
    Porter JH, Wiley JL, Balster RL.
    J Pharmacol Exp Ther; 1989 Mar 26; 248(3):997-1002. PubMed ID: 2539469
    [Abstract] [Full Text] [Related]

  • 11. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L, Wong EH, Kesingland AC, Tricklebank MD.
    Br J Pharmacol; 1990 Jan 26; 99(1):145-51. PubMed ID: 2158832
    [Abstract] [Full Text] [Related]

  • 12. (+)- and (-)-N-allylnormetazocine binding sites in mouse brain: in vitro and in vivo characterization and regional distribution.
    Compton DR, Bagley RB, Katzen JS, Martin BR.
    Life Sci; 1987 Jun 01; 40(22):2195-206. PubMed ID: 3035304
    [Abstract] [Full Text] [Related]

  • 13. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC, Janssen PA.
    J Pharmacol Exp Ther; 1984 Jul 01; 230(1):193-9. PubMed ID: 6747824
    [Abstract] [Full Text] [Related]

  • 14. (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] but not (-)-3-PPP produces (+)-N-allylnormetazocine-like (SKF 10,047) discriminative stimuli.
    Steinfels GF, Tam SW, Cook L.
    Life Sci; 1986 Dec 29; 39(26):2611-5. PubMed ID: 3796207
    [Abstract] [Full Text] [Related]

  • 15. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.
    Katz JL, Spealman RD, Clark RD.
    J Pharmacol Exp Ther; 1985 Feb 29; 232(2):452-61. PubMed ID: 3968644
    [Abstract] [Full Text] [Related]

  • 16. Stereoisomers of [3H]-N-allylnormetazocine bind to different sites in mouse brain.
    Martin BR, Katzen JS, Woods JA, Tripathi HL, Harris LS, May EL.
    J Pharmacol Exp Ther; 1984 Dec 29; 231(3):539-44. PubMed ID: 6094791
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine.
    Beardsley PM, Balster RL.
    J Pharmacol Exp Ther; 1988 Jan 29; 244(1):34-40. PubMed ID: 3336008
    [Abstract] [Full Text] [Related]

  • 18. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine.
    Tricklebank MD, Singh L, Oles RJ, Wong EH, Iversen SD.
    Eur J Pharmacol; 1987 Sep 23; 141(3):497-501. PubMed ID: 2822452
    [Abstract] [Full Text] [Related]

  • 19. (+)-N-Allylnormetazocine (NANM)-like discriminative stimulus effects of N-methyl-D-aspartate (NMDA) antagonists.
    Willetts J, Rice A, Balster RL.
    Behav Pharmacol; 1990 Sep 23; 1(5):453-458. PubMed ID: 11175430
    [Abstract] [Full Text] [Related]

  • 20. In vivo binding of [3H]d-N-allylnormetazocine and [3H]haloperidol to sigma receptors in the mouse brain.
    Weissman AD, Broussolle EP, London ED.
    J Chem Neuroanat; 1990 Sep 23; 3(5):347-54. PubMed ID: 2171560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.